These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)]. Pullmann H; Muth M Z Hautkr; 1982 Feb; 57(4):294-7. PubMed ID: 7080583 [No Abstract] [Full Text] [Related]
3. [Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)]. Wätzig V; Knopf B Arch Geschwulstforsch; 1979; 49(2):140-5. PubMed ID: 475550 [TBL] [Abstract][Full Text] [Related]
4. [Present concepts of the treatment of malignant melanoma (author's transl)]. Banzet P; Dufourmental C Acta Chir Belg; 1975 Jul; 74(4):395-405. PubMed ID: 1146460 [TBL] [Abstract][Full Text] [Related]
5. [Malignant melanoma of the skin. Current experiences in diagnosis, histoprognostic classification and therapy]. Romano S; De Marini F; Filippi B Minerva Chir; 1979 Nov; 34(22):1523-5. PubMed ID: 548830 [No Abstract] [Full Text] [Related]
7. Results of adjuvant BCG immunotherapy in malignant melanoma. Wätzig V; Knopf B Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442 [TBL] [Abstract][Full Text] [Related]
8. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report. Nathanson L; Clark DA Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321 [No Abstract] [Full Text] [Related]
9. [Medical therapy of malignant melanoma]. Mini E; Periti P Ann Ital Chir; 1989; 60(4):257-63. PubMed ID: 2699710 [No Abstract] [Full Text] [Related]
10. [Results in the use of immunochemotherapy in patients with cutaneous malignant melanoma]. Calbo L; Gorgone S; Palmeri R; Salibra M; Melita P Chir Ital; 1983 Aug; 35(4):519-25. PubMed ID: 6680859 [TBL] [Abstract][Full Text] [Related]
11. [Immunoreactivity in patients with surgically removed melanoma in the course of BCG vaccination (author's transl)]. Lochman I; Kyselá T; Machálek J; Lochmanová A; Beska F Cesk Dermatol; 1980; 55(6):372-7. PubMed ID: 7460040 [No Abstract] [Full Text] [Related]
12. [Combined immunotherapy and cytostatic therapy in stage II and III malignant melanoma (proceedings)]. Rundenstam CM Lakartidningen; 1978 Dec; 75(49):4568-9. PubMed ID: 723339 [No Abstract] [Full Text] [Related]
13. [Experiences with immune BCG therapy of malignant melanoma]. Altmeyer P; Nödl F Dtsch Med Wochenschr; 1978 Jul; 103(30):1214. PubMed ID: 668562 [No Abstract] [Full Text] [Related]
15. [Modern trends in the therapy of malignant melanoblastoma (author's transl)]. Richter J; Duchková H; Rus J; Kubíková M Cas Lek Cesk; 1976 Nov; 115(45):1385-9. PubMed ID: 1000546 [No Abstract] [Full Text] [Related]
16. [Combined treatment of patients with metastases of skin melanoma using cryotherapy]. Iavorskiĭ VV; Karaseva VV; Tokareva ZI Vopr Onkol; 1988; 34(7):799-803. PubMed ID: 3420821 [TBL] [Abstract][Full Text] [Related]
17. Randomized controlled trial of adjuvant chemoimmunotherapy with DTIC and BCG after complete excision of primary melanoma with a poor prognosis or melanoma metastases. Can Med Assoc J; 1983 Apr; 128(8):929-33. PubMed ID: 6339024 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of advanced or recurrent malignant melanoma]. Pettavel J; Banzet P Schweiz Med Wochenschr; 1970 Jun; 100(23):988-92. PubMed ID: 5524714 [No Abstract] [Full Text] [Related]